QCM Cayman’s Medifast MED Stock Holding History

QCM Cayman’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,202	Closed	-$236K	–	211
2020 Q4	$236K	Buy	+1,202	New	+$212K	0.24%	177
2019 Q1	–	Sell	-2,431	Closed	-$304K	–	85
2018 Q4	$304K	Buy	2,431 +1,388	+133%	+$237K	1.24%	24
2018 Q3	$231K	Buy	+1,043	New	+$211K	0.76%	56

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

QCM Cayman's MED Position: Q1 2021 in Review

QCM Cayman sold out of Medifast (MED) in Q1 2021, closing a stake of 1,202 shares — an estimated $236K sold.

QCM Cayman first reported a position in MED in Q3 2018 and held it in 3 quarters. The position peaked at $304K in Q4 2018. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

QCM Cayman reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
QCM Cayman sold 1,202 Medifast shares in Q1 2021, an estimated $236K.
QCM Cayman first reported a position in Medifast in Q3 2018 and held it in 3 quarters.
QCM Cayman's Medifast position peaked at $304K in Q4 2018.
277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on QCM Cayman's 13F filing for Q1 2021, filed 17 May 2021.